Nova Patents
ECSP12012218A

Piperidin-4-yl azetidine derivatives as jak1 inhibitors

Abstract

The present invention provides piperidin-4-yl azetidine derivatives, as well as its compositions and methods of use, which modulate the activity of Janus kinase (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 which includes, by For example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

141 members in 39 offices

This recordMember, by publication datePriority claim29 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
31258810United States of AmericaP
41560210United States of AmericaP

Members141

Family members, oldest first
DocumentOfficeKind
CA2792508A1CanadaA1
US2011224190A1United States of AmericaA1
WO2011112662A1World Intellectual Property Organization (WIPO)A1
TW201206923ATaiwan Province of ChinaA
AR081315A1ArgentinaA1
AU2011224484A1AustraliaA1
SG183551A1SingaporeA1
PH12012501768A1PhilippinesA1
MX2012010344AMexicoA
ECSP12012218AThis recordEcuadorA
CL2012002501A1ChileA1
CR20120510ACosta RicaA
EP2545045A1European Patent Office (EPO)A1
CO6602158A2ColombiaA2
PE20130038A1PeruA1
CN102985417AChinaA
KR20130038834ARepublic of KoreaA
EA201290894A1Eurasian Patent Organization (EAPO)A1
JP2013522214AJapanA
HK1177741AHong Kong, ChinaA
HK1177741A1Hong Kong, ChinaA1
ZA201207420BSouth AfricaB
US8765734B2United States of AmericaB2
NZ602313ANew ZealandA
US2014275031A1United States of AmericaA1
CN102985417BChinaB
AU2015205858A1AustraliaA1
UA110108C2UkraineC2
EP2545045B1European Patent Office (EPO)B1
DK2545045T3DenmarkT3
MX336932BMexicoB
JP5858484B2JapanB2
TWI531572BTaiwan Province of ChinaB
ES2569539T3SpainT3
HRP20160326T1CroatiaT1
JP2016094443AJapanA
SI2545045T1SloveniaT1
SMT201600085BSan MarinoB
EP3050882A1European Patent Office (EPO)A1
BR112012022513A2BrazilA2
PL2545045T3PolandT3
ME02386BMontenegroB
US9464088B2United States of AmericaB2
IL221823AIsraelA
RS54823B1SerbiaB1
TW201638088ATaiwan Province of ChinaA
HUE028723T2HungaryT2
AU2017201801A1AustraliaA1
AU2015205858B2AustraliaB2
PH12015502575A1PhilippinesA1
PH12015502575B1PhilippinesB1
CY1117435T1CyprusT1
MX347851BMexicoB
JP6158282B2JapanB2
TWI592413BTaiwan Province of ChinaB
JP2017149779AJapanA
US2017246157A1United States of AmericaA1
TW201734014ATaiwan Province of ChinaA
CA2792508CCanadaC
EP3050882B1European Patent Office (EPO)B1
MX354212BMexicoB
DK3050882T3DenmarkT3
ES2662588T3SpainT3
PT3050882TPortugalT
JP6318291B2JapanB2
KR101857680B1Republic of KoreaB1
KR20180054890ARepublic of KoreaA
LT3050882TLithuaniaT
HRP20180552T1CroatiaT1
US9999619B2United States of AmericaB2
SI3050882T1SloveniaT1
NO3050882T3NorwayT3
SMT201800137T1San MarinoT1
EA030376B1Eurasian Patent Organization (EAPO)B1
RS57219B1SerbiaB1
EP3354652A1European Patent Office (EPO)A1
JP2018118992AJapanA
HUE037077T2HungaryT2
PL3050882T3PolandT3
ME03002BMontenegroB
KR101911697B1Republic of KoreaB1
KR20180117206ARepublic of KoreaA
TWI643857BTaiwan Province of ChinaB
CY1120154T1CyprusT1
US2018353499A1United States of AmericaA1
TW201906613ATaiwan Province of ChinaA
MX364636BMexicoB
MX2019005232AMexicoA
AU2017201801B2AustraliaB2
EA201890558A1Eurasian Patent Organization (EAPO)A1
AU2019257385A1AustraliaA1
HK1258929AHong Kong, ChinaA
HK1258929A1Hong Kong, ChinaA1
KR20200033996ARepublic of KoreaA
EP3354652B1European Patent Office (EPO)B1
DK3354652T3DenmarkT3
TWI694826BTaiwan Province of ChinaB
MY175156AMalaysiaA
US10695337B2United States of AmericaB2
PT3354652TPortugalT
Showing 100 of 141